NDAINJECTIONINJECTABLEPriority Review
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
GALLIUM CITRATE GA 67 (gallium citrate ga-67) by Lantheus Medical Imaging is clinical pharmacology gallium citrate ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. First approved in 1976.
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Citrate GA-67 is a radioactive diagnostic imaging agent that concentrates in tumors and sites of infection for localization and detection. The mechanism of accumulation is unknown but involves lysosomal uptake and binding to intracellular proteins. It is administered by intravenous injection for diagnostic purposes in oncology and infectious disease imaging.
LOE Approaching
Product approaching loss of exclusivity with minimal linked job postings; declining commercial team investment expected.
Mechanism of Action
CLINICAL PHARMACOLOGY Gallium Citrate Ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. The mechanism of concentration is unknown, but investigational studies have shown that gallium Ga-67 accumulates in…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities on Gallium Citrate GA-67 are limited and tilted toward operational, compliance, and defensive commercial roles rather than growth functions. Working on this product offers experience managing legacy products through LOE but limited visibility for career advancement in a declining franchise.
Worked on GALLIUM CITRATE GA 67 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.